Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 8251 

September 7, 2021 to obtain comments 

from the public and affected agencies. 

CDC received two non-substantive 

comments related to the previous 

notice. This notice serves to allow an 

additional 30 days for public and 

affected agency comments. 

CDC will accept all comments for this 

proposed information collection project. 

The Office of Management and Budget 

is particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary for the 

proper performance of the functions of the 

agency, including whether the information 

will have practical utility; 

(b) Evaluate the accuracy of the agencies 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and assumptions 

used; 

(c) Enhance the quality, utility, and clarity 

of the information to be collected; 

(d) Minimize the burden of the collection 

of information on those who are to respond, 

including, through the use of appropriate 

automated, electronic, mechanical, or other 

technological collection techniques or other 

forms of information technology, e.g., 

permitting electronic submission of 

responses; and 

(e) Assess information collection costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570. 

Comments and recommendations for the 

proposed information collection should 

be sent within 30 days of publication of 

this notice to www.reginfo.gov/public/ 

do/PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. Direct written 

comments and/or suggestions regarding 

the items contained in this notice to the 

Attention: CDC Desk Officer, Office of 

Management and Budget, 725 17th 

Street NW, Washington, DC 20503 or by 

fax to (202) 395–5806. Provide written 

comments within 30 days of notice 

publication. 

Proposed Project 

HIV Prevention Capacity 

Development Needs Assessments of 

Federally funded Health Departments 

and Community-Based Organizations— 

New—National Center for HIV, Viral 

Hepatitis, STD, and TB Prevention 

(NCHHSTP), Centers for Disease Control 

and Prevention (CDC). 

Background and Brief Description 

The purpose of this data collection is 

to determine the training and technical 

assistance (TA) needs of health 

departments and community-based 

organizations (CBO) funded by CDC to 

conduct HIV prevention and 

surveillance activities. Data will be used 

to provide the training and TA funded 

agencies need in a timely and efficient 

manner by combining the responses and 

hosting trainings and TA with multiple 

agency staff at the same time. 

Data will be gathered by the CDC 

through two structured, survey-based 

assessments hosted on our online 

training and technical assistance request 

system. CDC is requesting a three-year 

approval in order to accommodate the 

multiple Notifications of Funding 

Opportunities (NOFO) that inform the 

U.S. HIV response system at the local 

and state level. 

CDC is requests OMB approval for an 

estimated 66 annual burden hours. 

There are no other costs to respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Community-based Organization Representatives—Adults.Community-based Organization Needs Assessment.130 1 15/60 

Health Department Representatives—Adults Health Department Needs Assessment ......... 70 1 15/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–03075 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CK22–006, 

Clinical and Applied Research Strategies for 

the Prevention and Control of Fungal 

Diseases. 

Date: April 14, 2022. 

Time: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for Disease 

Control and Prevention, Atlanta, GA 30329. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Gregory 

Anderson, M.S., M.P.H., Scientific Review 

Officer, CDC, National Center for HIV, Viral 

Hepatitis, STD, and TB Prevention, 1600 

Clifton Road NE, Mailstop US8–1, Atlanta, 

Georgia 30329, (404) 718–8833, ganderson@

cdc.gov. 

The Director, Strategic Business Initiatives 

Unit, Office of the Chief Operating Officer, 

Centers for Disease Control and Prevention, 

has been delegated the authority to sign 

Federal Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–03016 Filed 2–11–22; 8:45 am] 

BILLING CODE 4163–18–P 


jspears on DSK121TN23PROD with NOTICES1